About the Special Issue

In the last few years, treatment of gastrointestinal cancers has been updated significantly. For instance, total neoadjuvant treatment is the new standard of care in locally advanced rectal cancer and immunotherapy is the new best choice in the first-line treatment of MSI-high advanced colorectal carcinomas. Moreover, immunotherapy has improved treatment outcomes in esophageal, gastric cancer and has significantly changed life expectancy in liver cancer. This special issue aims at focusing at all the latest advances in the endoscopic, surgical and medical fields treatment for localized, locally advanced and metastatic gastrointestinal cancers, such as colorectal, gastric, esophageal, pancreatic, liver cancer. and cholangiocarcinoma.

Call for Papers